5-乙烯基尿嘧啶结构式
|
常用名 | 5-乙烯基尿嘧啶 | 英文名 | 5-vinyluracil |
---|---|---|---|---|
CAS号 | 37107-81-6 | 分子量 | 138.12400 | |
密度 | 1.332g/cm3 | 沸点 | N/A | |
分子式 | C6H6N2O2 | 熔点 | >300ºC (dec.)(lit.) | |
MSDS | 中文版 美版 | 闪点 | N/A | |
符号 |
GHS07 |
信号词 | Warning |
中文名 | 5-乙烯尿嘧啶 |
---|---|
英文名 | 5-ethenyl-1H-pyrimidine-2,4-dione |
中文别名 | 5-乙烯基尿嘧啶 | 5-乙烯基-1H-嘧啶-2,4-二酮 |
英文别名 | 更多 |
密度 | 1.332g/cm3 |
---|---|
熔点 | >300ºC (dec.)(lit.) |
分子式 | C6H6N2O2 |
分子量 | 138.12400 |
精确质量 | 138.04300 |
PSA | 65.72000 |
外观性状 | Powder |
折射率 | 1.606 |
储存条件 | -20°C Freezer |
计算化学 | 1.疏水参数计算参考值(XlogP):无 2.氢键供体数量:2 3.氢键受体数量:2 4.可旋转化学键数量:1 5.互变异构体数量:12 6.拓扑分子极性表面积58.2 7.重原子数量:10 8.表面电荷:0 9.复杂度:230 10.同位素原子数量:0 11.确定原子立构中心数量:0 12.不确定原子立构中心数量:0 13.确定化学键立构中心数量:0 14.不确定化学键立构中心数量:0 15.共价键单元数量:1 |
符号 |
GHS07 |
---|---|
信号词 | Warning |
危害声明 | H315-H319-H335 |
警示性声明 | P261-P305 + P351 + P338 |
个人防护装备 | dust mask type N95 (US);Eyeshields;Gloves |
危害码 (欧洲) | Xi: Irritant; |
风险声明 (欧洲) | 36/37/38 |
安全声明 (欧洲) | 26-36/37 |
危险品运输编码 | NONH for all modes of transport |
WGK德国 | 3 |
海关编码 | 2933599090 |
海关编码 | 2933599090 |
---|---|
中文概述 | 2933599090. 其他结构上有嘧啶环的化合物(包括其他结构上有哌嗪环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期 |
Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
A method for the rapid preparation of 5-vinyluracil in high yield.
Nucleic Acids Res. 1(1) , 105-7, (1974) A method for the rapid preparation of the thymineanalogue, 5-vinyluracil, in 83% yield from 5-(1-hydroxyethyl)uracil via the methanesulphonyl ester is reported. |
|
Design and synthesis of the tumor-activated prodrug of dihydropyrimidine dehydrogenase (DPD) inhibitor, RO0094889 for combination therapy with capecitabine.
Bioorg. Med. Chem. Lett. 13(5) , 867-72, (2003) A series of tumor-activated prodrugs of the inhibitors of dihydropyrimidine dehydrogenase (DPD), an enzyme catabolizing 5-fluorouracil (5-FU: 4g), has been designed and synthesized. RO0094889 (11c) is... |
|
Incorporation of 5-substituted uracil derivatives into nucleic acids. The isolation and gamma-radiation-sensitivity of bacteriophage T3 containing the thymine analogue 5-vinyluracil.
Biochem. J. 187(1) , 257-60, (1980) Bacteriophage T3 was produced in a form that contained 32% of its normal DNA thymine residues replaced with 5-vinyluracil residues by infecting a thymine-requiring strain of Escherichia coli with phag... |
5-ethenyluracil |
5-vinyl-1H-pyrimidine-2,4-dione |
MFCD00913267 |
5-ethenyl-2,4(1H,3H)-pyrimidinedione |
5-Vinyl-uracil |
5-ethenylpyrimidine-2,4-diol |